- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00937807
Hemodynamic Stability During Carotid Endarterectomy.Comparison of LENOXe™ (Xenon 100% v/v) Versus Sevoflurane
June 29, 2010 updated by: Air Liquide Santé International
Hemodynamic Stability During Carotid Endarterectomy Under General Anesthesia in Elderly Patients: Comparison LENOXe™ (xénon 100% v/v) Versus SEVOFLURANE
The purpose of this study is to compare the hemodynamics effects of two usual hypnotic agents (LENOXe ™ (xenon 100 % v/v) and sevoflurane) during a general anesthesia for carotid endarterectomy in elderly patients.
The hypothesis is that the use of the LENOXe ™ (xenon 100 % v/v) allows to obtain per-operating hemodynamic stability non inferior than with sevoflurane.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
84
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France, 75013
- Hospital Pitie-Salpetriere
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients > 55 years, status ASA II
- Carotid endarterectomy elected surgery
- Signed informed consent
Exclusion Criteria:
Related to the patients:
- Histories of hypersensibility in both products used in the study
- uncontrolled arterial High Blood Pressure in the preoperative anaesthesia screening
- Severe cardiac failure (FEVG < 30 %)
- Major lung or airways disease and\or required per-operating FiO2> 35 %
- Elevated intracranial pressure
- Pregnancy, breast feeding
- Major protected, under supervision, under guardianship
- Every patient entering within the framework of the contraindications indicated to §4.3 of the summary of the characteristics of tested products (LENOXe ™ (xenon 100 % v/v), sevoflurane)
Related to the surgery:
- Controlateral carotid stenosis superior to 70 % and\or preoperative indication in the implementation per-operating of a carotid shunt
- Surgery realized within the framework of an emergency
- Combined Surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: sévoflurane
hypnotic use in standard general anesthesia
|
Inhalation gas; dose allowed: 1,4 %; the duration of the treatment will be defined through anesthesia-time for a carotid surgery
|
EXPERIMENTAL: LENOXe™ (xénon 100 % v/v)
Safety of use in terms of hemodynamic stability to the LENOXe™ (xénon 100 % v/v) within the framework of the carotid surgery on the old person
|
Inhalational gas; dose allowed: 60 % Xenon; the duration of the treatment will be defined through anesthesia-time for a carotid surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Standard deviation of the values of systolic blood pressure (SBP)collected per-operatively every minutes(BIOPAC ® MP150) Values of SBP over or under thresholds during and out of the clamping period, if so vasopressive/ hypotensive treatment used
Time Frame: Pre-op, every min from 1-90 min during maintenance phase
|
Pre-op, every min from 1-90 min during maintenance phase
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
cardiovascular, general, hepatic and renal tolerance to xenon. Quality and time of awakening, recovery index (IR);Post-op pain (EVA)and consumption of analgesic; Inflammatory Syndrome (cytokine profile); Subjective comfort of the patient
Time Frame: During the whole anesthetic procedure and the postoperating time until 24 hours after discharge from the recovery room / intensive care unit and return to the ward
|
During the whole anesthetic procedure and the postoperating time until 24 hours after discharge from the recovery room / intensive care unit and return to the ward
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Pierre CORIAT, Pr, Groupe Hospitalier Pitie-Salpetriere
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2009
Primary Completion (ACTUAL)
February 1, 2010
Study Completion (ACTUAL)
April 1, 2010
Study Registration Dates
First Submitted
July 9, 2009
First Submitted That Met QC Criteria
July 10, 2009
First Posted (ESTIMATE)
July 13, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
June 30, 2010
Last Update Submitted That Met QC Criteria
June 29, 2010
Last Verified
June 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ALS-8-09-A-401
- EUDRACT 2009-012810-29
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodynamic Stability
-
KIST Medical and Teaching HospitalRecruiting
-
William C. OliverTerminatedHemodynamic StabilityUnited States
-
Erasme University HospitalUniversity of California, Los Angeles; University of California, IrvineCompletedHemodynamic MAP StabilityBelgium
-
Erasme University HospitalUniversity of California, Los Angeles; University of California, IrvineCompletedHemodynamic (MAP) StabilityBelgium
-
Indus Hospital and Health NetworkCompletedHemodynamic Stability Post Intubation in Laryngoscopy SurgeryPakistan
-
Tanta UniversityCompletedHemodynamic Stability | Analgesic Effects | Systemic Stress ResponseEgypt
-
Sheikh Zayed Medical CollegeNot yet recruiting
-
Kasr El Aini HospitalRecruitingThe Effect of Ketamine - Dexmedetomidine Admixture (Ketodex) on Hemodynamic StabilityEgypt
-
Hospital Clínico Universitario de ValenciaRecruitingHip Fractures | Hemodynamic StabilitySpain
-
Fernando Suarez SipmannAir Liquide SARecruitingHemodynamic Stability | Collapsed LungSpain
Clinical Trials on sévoflurane
-
Nantes University HospitalFondation ApicilNot yet recruitingPersistent Postoperative Pain